Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progression
Guillaume Dorcet, Hugo Migné, Damien Biotti, Chloé Bost, Fleur Lerebours, Jonathan Ciron, Emmanuel Treiner
Topics & Concepts
RituximabMedicineNeurologyInternal medicineMultiple sclerosisNeuroradiologyB cellProspective cohort studyOncologyImmunologyAntibodyLymphomaPsychiatryMultiple Sclerosis Research StudiesT-cell and B-cell ImmunologyPeripheral Neuropathies and Disorders